Avricore Health Inc Revenue per Employee (VANC), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Avricore Health Inc   (VANC)
 

Avricore Health Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 79.01% in the fourth quarter 2024, year on year to cumulative value of $3 million, Avricore Health Inc 's revenue per employee grew on a trailing twelve months basis to $ 3,440,300. The productivity of Avricore Health Inc 's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 355 other companies have achieved higher revenue per employee. While revenue/employee total ranking has improved so far to 2799, from total ranking in previous quarter at 3310. Avricore Health Inc has 1 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

VANC Revenue per Employee (Dec 31 2024)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2023)
IV. Quarter
Y / Y Revenue Change 79.01 % - - - 41.87 %
Sales per Employee (TTM) $ 3,440,300 1,921,801 2,632,888 3,021,688 3,021,688
VANC's Total Ranking # 2799 # 3310 # # #
Seq. Revenue Change - - - - 170.26 %

VANC Company Profile >> Back to VANC Efficiency Comparisons >> Compare VANC Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 163
Healthcare Sector # 356
Overall Market # 2799

Revenue per Employee Statistics
High Average Low
$ 286,692 $ 141,891 $ 7,839
(Dec 31 2024)   (Dec 31 2021)



Financial Statements
Avricore Health Inc 's Revenue MRQ $ 3 Millions Visit VANC's Income Statement
Avricore Health Inc 's Revenues TTM $ 3 Millions Visit VANC's aggregate revenue growth
What are VANC's Sales? Visit VANC's Sales by Segment




Other Ratios
Avricore Health Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
VANC's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for VANC's Competitors
Revenue per Employee for VANC's Suppliers
Revenue per Employee for VANC's Customers

You may also want to know
VANC's Sales Growth Rates VANC's Pe Price to earnings ratio VANC's Receivables Turnover Ratio VANC's Stock Quote
VANC's Net Income Growth Rates VANC's Ps Price to Sales ratio VANC's Sales per Employee VANC's Asset Turnover Ratio
VANC's Net Margin VANC's Pb Price to Book ratio VANC's Financial Strength Ratios VANC's Dividend Payout Ratio
Date modified: 2026-10-07T00:41:54+00:00




Companies with similar Revenue per Employee for 12 months ending Dec 31 2024, within Healthcare Sector Revenue per Employee Revenue 12 months ending Dec 31 2024Number of Employees Dec 31 2024
American Oncology Network Inc   5,864,946.67 $ 1,759.484  Million 300 
Anika Therapeutics Inc   5,625,857.14 $ 118.143  Million 21 
P3 Health Partners Inc   4,688,921.88 $ 1,500.455  Million 320 
Community Health Systems Inc   4,075,483.87 $ 12,634.000  Million 3,100 
Ascendis Pharma A  3,934,594.17 $ 393.459  Million 100 
Pulmatrix Inc   3,903,000.00 $ 7.806  Million 2 
Argenx Se  3,869,573.17 $ 4,442.270  Million 1,148 
Ligand Pharmaceuticals Incorporated  3,556,021.28 $ 167.133  Million 47 
Ironwood Pharmaceuticals inc   3,514,100.00 $ 351.410  Million 100 
Illumina Inc   3,415,625.00 $ 4,372.000  Million 1,280 
Avricore Health Inc   3,401,538.06 $ 3.402  Million 1 
Intra cellular Therapies Inc   3,370,554.46 $ 680.852  Million 202 
Protagonist Therapeutics inc   3,291,159.09 $ 434.433  Million 132 
Xeris Biopharma Holdings Inc   3,124,153.85 $ 203.070  Million 65 
Equillium Inc   2,935,357.14 $ 41.095  Million 14 
Siga Technologies Inc  2,831,007.14 $ 138.719  Million 49 
Catalyst Pharmaceuticals Inc   2,701,835.16 $ 491.734  Million 182 
Innoviva Inc   2,628,125.79 $ 417.872  Million 159 
Amgen Inc   2,571,076.92 $ 33,424.000  Million 13,000 
Harmony Biosciences Holdings inc   2,436,583.62 $ 713.919  Million 293 
Grifols Sa  2,428,818.69 $ 7,803.794  Million 3,213 
Halozyme Therapeutics Inc   2,400,293.14 $ 1,015.324  Million 423 
Assertio Holdings inc   2,357,754.72 $ 124.961  Million 53 
Springworks Therapeutics Inc   2,280,821.43 $ 191.589  Million 84 
Sarepta Therapeutics Inc   2,277,819.16 $ 1,901.979  Million 835 
Indivior Pharmaceuticals Inc   2,078,000.00 $ 2,078.000  Million 1,000 
United Therapeutics Corporation  2,055,285.71 $ 2,877.400  Million 1,400 
Xoma Royalty Corporation  2,034,785.71 $ 28.487  Million 14 
Prothena Corporation Public Limited Company  2,017,268.66 $ 135.157  Million 67 
Cytomx Therapeutics Inc   2,001,492.75 $ 138.103  Million 69 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.